Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayani Pathirana

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2025
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8Paul T Scott, Jayani Pathirana, Akira Kato, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
An Observational Pilot Study Evaluating the Utility of Minimally Invasive Tissue Sampling to Determine the Cause of Stillbirths in South African WomenShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Unraveling Specific Causes of Neonatal Mortality Using Minimally Invasive Tissue Sampling: An Observational StudyShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Human Vaccines & Immunotherapeutics|June 23, 2026
A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)Vinita Jagannath, Jayani Pathirana, Carlos Alberto Perez Yepes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Potential of Minimally Invasive Tissue Sampling for Attributing Specific Causes of Childhood Deaths in South Africa: A Pilot, Epidemiological StudyRichard Chawana, Vicky Baillie, Alane Izu, et al.
The Lancet. Infectious Diseases|February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyGrant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases|July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases|June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studiesGrant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2025
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8Paul T Scott, Jayani Pathirana, Akira Kato, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
An Observational Pilot Study Evaluating the Utility of Minimally Invasive Tissue Sampling to Determine the Cause of Stillbirths in South African WomenShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Unraveling Specific Causes of Neonatal Mortality Using Minimally Invasive Tissue Sampling: An Observational StudyShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Human Vaccines & Immunotherapeutics|June 23, 2026
A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)Vinita Jagannath, Jayani Pathirana, Carlos Alberto Perez Yepes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Potential of Minimally Invasive Tissue Sampling for Attributing Specific Causes of Childhood Deaths in South Africa: A Pilot, Epidemiological StudyRichard Chawana, Vicky Baillie, Alane Izu, et al.
The Lancet. Infectious Diseases|February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyGrant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases|July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases|June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studiesGrant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Pageof 2